Ignite Creation Date:
2025-12-24 @ 10:48 PM
Ignite Modification Date:
2026-02-20 @ 11:49 PM
Study NCT ID:
NCT05506969
Status:
COMPLETED
Last Update Posted:
2025-07-29
First Post:
2022-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age
Sponsor:
Dynavax Technologies Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DV2-PLG-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | FED | View |